Sulfatrim and Plavix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sulfatrim (sulfamethoxazole; trimethoprim) and Plavix (clopidogrel bisulfate). Common drug interactions include headache among females and influenza among males.

The phase IV clinical study analyzes what interactions people have when they take Sulfatrim and Plavix. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Sulfatrim?

Sulfatrim has active ingredients of sulfamethoxazole; trimethoprim. eHealthMe is studying from 4,140 Sulfatrim users. Check the latest studies of Sulfatrim.

What is Plavix?

Plavix has active ingredients of clopidogrel bisulfate. It is often used in stent. eHealthMe is studying from 151,179 Plavix users. Check the latest studies of Plavix.



On Aug, 07, 2026

25 people who take Sulfatrim and Plavix together, and have interactions are studied.

Sulfatrim and Plavix drug interactions.

What are the common drug interactions of Sulfatrim and Plavix, by gender? *:

female:

  1. Headache (pain in head)
  2. Alopecia (absence of hair from areas of the body)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Arthralgia (joint pain)
  5. Arthropathy
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Cystitis (inflammation of the wall of the bladder)
  8. Fall
  9. Fatigue (feeling of tiredness)
  10. Fluid retention (an abnormal accumulation of fluid in the blood)

male:

  1. Influenza
  2. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  3. Impaired healing
  4. Muscle cramps (painful sensations caused by muscle contraction)
  5. Nausea (feeling of having an urge to vomit)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Skin ulcer
  8. Urinary retention postoperative
  9. Weight decreased
  10. White blood cell count increased

What are the common drug interactions of Sulfatrim and Plavix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Breast cancer recurrent

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal wall abscess (abdominal wall infection)
  2. Adverse drug reaction
  3. Arrhythmia (irregular heartbeat)
  4. Asthma
  5. Cardiac failure congestive
  6. Cystitis (inflammation of the wall of the bladder)
  7. Decreased appetite
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  10. Encephalitis (inflammation of the brain)

50-59:

  1. Acute myocardial infarction (acute heart attack)
  2. Hypertension (high blood pressure)
  3. Impaired healing
  4. Skin ulcer
  5. Type 2 diabetes mellitus

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Alopecia (absence of hair from areas of the body)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Necrosis (the death of body tissue)
  5. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  6. Polymyalgia rheumatica (pain in many muscles)
  7. Speech disorder
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Vomiting
  10. Bladder transitional cell carcinoma (types of bladder cancer)

What are the existing conditions these people have? *

  1. High Blood Pressure: 11 people, 44.00%
  2. Multiple Myeloma (cancer of the plasma cells): 8 people, 32.00%
  3. Constipation: 8 people, 32.00%
  4. Pain: 6 people, 24.00%
  5. Anaemia (lack of blood): 6 people, 24.00%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 24.00%
  7. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 20.00%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 20.00%
  9. Hypokalemia (low potassium): 4 people, 16.00%
  10. High Blood Cholesterol: 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sulfatrim and Plavix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sulfatrim and Plavix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sulfatrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Plavix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sulfatrim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plavix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim and clopidogrel bisulfate (the active ingredients of Sulfatrim and Plavix, respectively), and Sulfatrim and Plavix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: